May 30, 1995

The present invention relates to novel 2-substitited indane-2-mercaptoacetylamide tricyclic derivatives which are useful as inhibitors of Enkephalise.

13

May 30, 1995

08/078,787

June 17, 1993

540/521   540/520

C07D   487/00   (20060101)   C07D   498/00   (20060101)   C07D   498/04   (20060101)   C07D   513/04   (20060101)   C07D   513/00   (20060101)   C07D   471/00   (20060101)   C07D   487/04   (20060101)   C07D   471/04   (20060101)  

This is a Continuation-In-Part Application of patent application Ser. No. 07/934,833, filed Aug. 24, 1992, now abandoned.

540/321   340/322  

	5491141 - 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase - Owned by Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH) The present invention relates to novel 2-substitited indane-2-mercaptoacetylamide tricyclic derivatives which are useful as inhibitors of Enkephalise.
	5491142 - 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase - Owned by Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH) The present invention relates to novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives which are useful as inhibitors of Enkephalise.
	6774125 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds - Owned by Elan Pharmaceuticals, Inc. (South San Francisco, CA) Eli Lilly & Company (Indianapolis, IN) Disclosed are compounds which inhibit .beta.-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits .beta.-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
	6509331 - Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds - Owned by Elan Pharmaceuticals, Inc. (South San Francisco, CA) Eli Lilly & Company (Indianapolis, IN) Disclosed are compounds which inhibit .beta.-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits .beta.-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
	6906056 - Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds - Owned by Elan Pharmaceuticals, Inc. (South San Francisco, CA) Eli Lilly & Company (Indianapolis, IN) Disclosed are compounds which inhibit .beta.-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits .beta.-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.